| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.26 | 9e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |